Javascript must be enabled to continue!
Cluster Analysis Identifies Clinical Phenotypes of Primary Hyperhidrosis
View through CrossRef
Introduction: Identifying subgroups of patients with primary hyperhidrosis (PHH) can improve the understanding of the disease pathophysiology. The study objective was to determine the naturally occurring subgroups of patients with PHH based on clinical characteristics. Methods: In this retrospective cohort study, data were collected from participants included in a clinical trial. The data were collected between January 2020 and June 2021 from outpatients with PHH attending a dermatologic department in Denmark. Overall, 84 patients with PHH were screened for inclusion in the clinical trial. Of these, 41 met the eligibility criteria. Four participants were excluded because of missing data. The main outcome was the identification of subgroups of patients with PHH using an unsupervised hierarchical cluster analysis. Results: Overall, 37 patients were included {28 (76.7%) females; median age at inclusion 28.0 (interquartile range [IQR] 24.0–38.3); median body mass index 24.9 (IQR 20.9–27.4); median age of onset 13.0 (IQR 9.5–18.5); and 26 (70.3%) had a familial disposition toward PHH}. Two clusters of 18 and 17 patients were identified. The first cluster had, when compared to the second, a younger age of onset (median age 11.0 [IQR 0–13.0] vs. 17.0 [IQR 15.0–21.0], p = 0.003) and higher sweat rates on gravimetry (median 175.0 [IQR 121.2–252.5] vs. 40.0 [IQR 20.0–60.0] milligrams of sweat/5 min, p < 0.001) and transepidermal water loss (median 93.7 [IQR 91.2–97.8] vs. 59.0 [IQR 44.4–73.2] g/m2/h, p < 0.001). No differences were observed for the other variables. Conclusions: This study identifies 2 subgroups of patients with PHH. The patients with an onset of PHH during childhood had a substantially higher sweat and evaporation rate in adulthood than those with an onset during adolescence. These findings may imply a changed understanding of the pathophysiology of PHH, by indicating that an early disease onset can lead to a worse disease course.
Title: Cluster Analysis Identifies Clinical Phenotypes of Primary Hyperhidrosis
Description:
Introduction: Identifying subgroups of patients with primary hyperhidrosis (PHH) can improve the understanding of the disease pathophysiology.
The study objective was to determine the naturally occurring subgroups of patients with PHH based on clinical characteristics.
Methods: In this retrospective cohort study, data were collected from participants included in a clinical trial.
The data were collected between January 2020 and June 2021 from outpatients with PHH attending a dermatologic department in Denmark.
Overall, 84 patients with PHH were screened for inclusion in the clinical trial.
Of these, 41 met the eligibility criteria.
Four participants were excluded because of missing data.
The main outcome was the identification of subgroups of patients with PHH using an unsupervised hierarchical cluster analysis.
Results: Overall, 37 patients were included {28 (76.
7%) females; median age at inclusion 28.
0 (interquartile range [IQR] 24.
0–38.
3); median body mass index 24.
9 (IQR 20.
9–27.
4); median age of onset 13.
0 (IQR 9.
5–18.
5); and 26 (70.
3%) had a familial disposition toward PHH}.
Two clusters of 18 and 17 patients were identified.
The first cluster had, when compared to the second, a younger age of onset (median age 11.
0 [IQR 0–13.
0] vs.
17.
0 [IQR 15.
0–21.
0], p = 0.
003) and higher sweat rates on gravimetry (median 175.
0 [IQR 121.
2–252.
5] vs.
40.
0 [IQR 20.
0–60.
0] milligrams of sweat/5 min, p < 0.
001) and transepidermal water loss (median 93.
7 [IQR 91.
2–97.
8] vs.
59.
0 [IQR 44.
4–73.
2] g/m2/h, p < 0.
001).
No differences were observed for the other variables.
Conclusions: This study identifies 2 subgroups of patients with PHH.
The patients with an onset of PHH during childhood had a substantially higher sweat and evaporation rate in adulthood than those with an onset during adolescence.
These findings may imply a changed understanding of the pathophysiology of PHH, by indicating that an early disease onset can lead to a worse disease course.
Related Results
The quality of life and satisfaction rate of patients with upper limb hyperhidrosis before and after bilateral endoscopic thoracic sympathectomy
The quality of life and satisfaction rate of patients with upper limb hyperhidrosis before and after bilateral endoscopic thoracic sympathectomy
Background:
Hyperhidrosis is a functional disorder identified by excessive sweating. Its incidence is approximately 1% in any population. Bilateral endoscopic thoracic ...
T3-T5 Thoracoscopic sympathectomy versus sympathicotomy in the treatment of palmar–axillary–plantar hyperhidrosis
T3-T5 Thoracoscopic sympathectomy versus sympathicotomy in the treatment of palmar–axillary–plantar hyperhidrosis
Background
Compensatory hyperhidrosis is a common complication after thoracoscopic interruption of the sympathetic chain in hyperhidrosis patients. Nonetheless, no inte...
Quality of Life After Endoscopic Lumbar Sympathectomy for Primary Plantar Hyperhidrosis
Quality of Life After Endoscopic Lumbar Sympathectomy for Primary Plantar Hyperhidrosis
AbstractBackgroundPrimary plantar hyperhidrosis is characterised by excessive secretion of the sweat glands of the feet and may lead to significant limitations in private and profe...
Efficacy and Safety of Glycopyrronium Bromide 1% Cream in Axillary and Extra‐Axillary Primary Hyperhidrosis: A Real‐Life Two‐Center Experience on 68 Subjects
Efficacy and Safety of Glycopyrronium Bromide 1% Cream in Axillary and Extra‐Axillary Primary Hyperhidrosis: A Real‐Life Two‐Center Experience on 68 Subjects
Introduction:
Primary hyperhidrosis (PH) is a common disorder affecting approximately 1% of the general population, characterized by focal sweating in excess of...
Topical Oxybutynin 3% Gel versus Aluminum Chloride 15% Lotion in Treatment of Primary Focal Hyperhidrosis
Topical Oxybutynin 3% Gel versus Aluminum Chloride 15% Lotion in Treatment of Primary Focal Hyperhidrosis
Introduction: Hyperhidrosis is excessive sweating beyond thermoregulatory needs. It is a potentially disabling condition with challenging management. Aluminum chloride is the estab...
CLINICAL EVALUATION OF A DOUBLE-PASS MICROWAVE DEVICE FOR TREATING AXILLARY HYPERHIDROSIS AND BROMHIDROSIS
CLINICAL EVALUATION OF A DOUBLE-PASS MICROWAVE DEVICE FOR TREATING AXILLARY HYPERHIDROSIS AND BROMHIDROSIS
ABSTRACT
Objectives: Microwave thermolysis (MWT) is a permanent treatment for axillary hyperhidrosis and bromhidrosis/osmidrosis. The study aims to evaluate the effectiveness and ...
Efficacy of Thoracoscopic Sympathectomy Including Asymmetric Resection for Treating Palmar Hyperhidrosis : A Retrospective Study
Efficacy of Thoracoscopic Sympathectomy Including Asymmetric Resection for Treating Palmar Hyperhidrosis : A Retrospective Study
Abstract
Objective:This study aims to retrospectively evaluate the effectiveness of single-segment thoracic sympathotomy in treating palmar hyperhidrosis.
Methods:We conduc...
Management of Postsurgical Hyperhidrosis With Direct Current and Tap Water
Management of Postsurgical Hyperhidrosis With Direct Current and Tap Water
Abstract
Background and Purpose. Excessive sweating, known as hyperhidrosis, involves the eccrine sweat glands of the axillae, soles, palms, and/or forehead. The use...

